Cite
HARVARD Citation
Wang, Y. et al. (2016). Polydatin ameliorates lipid and glucose metabolism in type 2 diabetes mellitus by downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9). Cardiovascular diabetology. 15 (1), pp. 1-13. [Online].